Clinical use of recombinant factor VIII Fc and recombinant factor IX Fc in patients with haemophilia A and B.
Cassandra P WangGuy Aaron YoungPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2018)
This study demonstrates the largely successful transition of 36 patients from SHL to EHL factor products.